Key facts
- This page summarizes Abbas Hussain's Form 4 filing for Moderna, Inc. (MRNA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 08 May 2026, 17:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.